Shares of clinical-stage DNA vaccine maker Inovio Pharmaceuticals Inc. (INO) have gained more than 60 percent over the last 5 trading days as the deadly Chinese coronavirus outbreak continues to make headlines in the news.
from RTT - Biotech https://ift.tt/2GtFcg3
via IFTTT
No comments:
Post a Comment